Evidence map›Paper›PMID 34292784›Full record

ArticleCirculation research2021

Multiple Cell Death Programs Contribute to Myocardial Infarction.

Xiaotong F Jia, Felix G Liang, Richard N Kitsis

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Circulation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Vericiguat reduces pyroptosis in rats with coronary microembolization by inhibiting the AMPK/Nrf2/NLRP3 signaling pathway.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A novel pyroptosis-related gene signature for predicting laryngeal carcinoma prognosis.International journal of clinical and experimental pathology · 2022
    Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Xiaotong F JiaCell Biology (X.F.J., F.G.L., R.N.K.), Albert Einstein College of Medicine, Bronx, NY.
Felix G LiangCell Biology (X.F.J., F.G.L., R.N.K.), Albert Einstein College of Medicine, Bronx, NY.
Richard N KitsisDepartments of Medicine (Cardiology) (R.N.K.), Albert Einstein College of Medicine, Bronx, NY.

Funding

Chaperone-Mediated Autophagy in Normal Cardiac Biology and Heart FailureR01HL138475 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KITSIS, RICHARD N · 2017 to 2020
$2.4M
Mechanisms of cardiovascular diseaseT32HL144456 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Carlos Jose Rodriguez, Nicholas E Sibinga · 2019 to 2026
$1.9M
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agentsR21CA235139 · NCI · BARUCH S. BLUMBERG INSTITUTE · PI PESTELL, RICHARD G · 2020 to 2020
$383k
NCI NIH HHS R21 CA235139NHLBI NIH HHS R01 HL138475NHLBI NIH HHS T32 HL144456
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myocardial InfarctionCell DeathHumansapoptosiscell deathEditorialsheart failuremyocardial infarctionpyroptosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.